← Leaderboards
Laura B Ramsey
Cincinnati Childrens Hosp Med Ctr
$1,878,658
Attributed
$3,757,315
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $855.3K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,757,315 · 3
By mechanism
R01$2,883,280 · 1
T32$874,035 · 2
Top collaborators
- Jeffrey Robert Strawn6 shared
- Jonathan Wagner3 shared
- Sonya C Tang Girdwood1 shared
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Senthilkumar Sadhasivam$17,658,675
- Vidya Chidambaran$7,050,743
- Leanne Tamm$2,583,307
- Rebecca Shaffer$2,551,933
- Steve Wei Wu$1,160,201
Others in their field
Other Emerging Leaders on “Child”
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$29,616,650
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,898,304
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Beth Baseler · Leidos Biomedical Research, Inc.$22,470,677
- Gaurav J Dave · Duke University$17,082,764
Research focus
ChildChildhoodFda ApprovedEffectivenessEscitalopramAdolescentAdultAnxietyAnxiety SymptomsAgitationAffectBlindedBody Mass IndexDrug KineticsFamily RelationshipChildhood AnxietyAnxiety DisordersAgedCyp2c19 GeneCyp2d6 GeneAnxiousDistressDoseGenes
Grant awards (10)
Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology$303,495
T32 · FY2025 · HD
Improving the Effectiveness and Safety of Escitalopram in Pediatric Anxiety$556,564
R01 · FY2024 · HD
Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology$298,713
T32 · FY2024 · HD
Improving the Effectiveness and Safety of Escitalopram in Pediatric Anxiety$424,833
R01 · FY2023 · HD
Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology$231,886
T32 · FY2023 · HD
Improving the Effectiveness and Safety of Escitalopram in Pediatric Anxiety Disorders Using Pharmacogenetically-guided Dosing$124,767
R01 · FY2023 · HD · contact PI
Improving the Effectiveness and Safety of Escitalopram in Pediatric Anxiety Disorders Using Pharmacogenetically-guided Dosing$549,601
R01 · FY2022 · HD · contact PI
T32 Cincinnati Pediatric Clinical Pharmacology Training Program$39,941
T32 · FY2022 · HD
Improving the Effectiveness and Safety of Escitalopram in Pediatric Anxiety Disorders Using Pharmacogenetically-guided Dosing$546,930
R01 · FY2021 · HD · contact PI
Improving the Effectiveness and Safety of Escitalopram in Pediatric Anxiety Disorders Using Pharmacogenetically-guided Dosing$680,585
R01 · FY2020 · HD · contact PI